Europe stocks hit fresh record high on earnings, Ukraine peace hopes

Europe stocks hit fresh record high on earnings, Ukraine peace hopes


European stock markets were broadly higher Thursday, amid a flurry of earnings and economic data and rising hopes of an end to the Russia-Ukraine war.

The regional Stoxx 600 index maintained positive momentum from earlier this week, when it marked three record closing highs, gaining another 0.74% by midday in London to hit another all-time intraday peak.

Markets held onto gains even as investors brace for a new swathe of tariffs to potentially be announced by U.S. President Donald Trump, who posted on social media in the early U.S. hours: “TODAY IS THE BIG ONE: RECIPROCAL TARIFFS!!!”

Those retaliatory duties are expected to hit every country which imposes import duties on the U.S., though exemptions for some sectors are reportedly being considered.

Top posts

  • Nestle full-year sales growth declines in line with expectations, points to uptick in 2025 | view post
  • Commerzbank to cut 3,900 jobs as it unveils new targets | view post
  • Europe must ‘pull back’ on regulation, Siemens CEO says as profits beat expectations | view post
  • UK economy ekes out 0.1% growth in fourth quarter | view post
  • Barclays posts 2024 pretax profit hike, launches £1 billion share buyback | view post

In European markets, German technology conglomerate Siemens was among the top performers, up 5.6% after reporting better than expected first-quarter profits, despite a “significant decline” at its factory automation business.

However, the U.K.’s FTSE 100 dropped 0.58%, weighed down by declines in banking and oil and gas stocks. Shares of British bank Barclays were 5.4% lower, despite the lender posting a slight beat on full-year pre-tax profit and announcing a £1 billion ($1.25 billion) share buyback. Consumer goods giant Unilever was meanwhile down 7% on weaker sales growth figures than forecast.

Investors are also assessing figures from the Office for National Statistics which showed the U.K. economy grew by 0.1% in the fourth quarter, ahead of expectations for a 0.1% contraction.

“Fourth-quarter UK GDP wasn’t as bad as it could have been, though the details weren’t great … all of the increase in GDP across 2024 can be put down to population growth. GDP per capita actually fell slightly across the year,” ING developed markets economist, James Smith, said in a note.

The gains for markets also come as an end to the Ukraine-Russia war becomes a more distinct prospect.

U.S. President Donald Trump said on Wednesday that he had spoken to both Russian President Vladimir Putin and Ukrainian President Volodymyr Zelenskyy, and that both leaders wanted peace. He said he had ordered U.S. officials to begin talks immediately on ending the war.



Source

Google joins Microsoft in telling users Anthropic is still available outside defense projects
World

Google joins Microsoft in telling users Anthropic is still available outside defense projects

Google CEO Sundar Pichai gestures to the crowd during Google’s annual I/O developers conference in Mountain View, California, on May 20, 2025. David Paul Morris | Bloomberg | Getty Images Google said it will continue offering Anthropic’s artificial intelligence technology for clients, excluding for defense work, a day after Microsoft issued a similar statement to […]

Read More
Market turmoil is hitting most traditional safe havens. UBS says this is the place to hide
World

Market turmoil is hitting most traditional safe havens. UBS says this is the place to hide

The U.S. and Israel are showing signs of escalating their war against Iran – a move that could batter a variety of assets, even traditional safe havens. To protect their portfolios, investors can snap up stocks from an oft-shorted sector: pharmaceuticals, UBS analysts say. Since the first strikes last Saturday, the Iran War has roiled […]

Read More
Zealand’s stock falls 35% after disappointing drug result. Its CEO tells CNBC people need to focus less on the ‘weight loss Olympics’
World

Zealand’s stock falls 35% after disappointing drug result. Its CEO tells CNBC people need to focus less on the ‘weight loss Olympics’

Wegovy is produced by pharmaceutical company Novo Nordisk and has been approved for specifically for chronic weight management in adults and adolescents. (Photo by Steve Christo – Corbis/Corbis via Getty Images) Steve Christo – Corbis | Corbis News | Getty Images The chief executive of drugmaker Zealand Pharma sought to calm investors about the latest […]

Read More